N. Heurlin, TREATMENT OF MYCOBACTERIAL INFECTIONS IN HIV-NEGATIVE IMMUNOCOMPROMISED PATIENTS, Scandinavian journal of infectious diseases, 1995, pp. 21-21
Rifabutin is a useful drug in the treatment of patients with rifampici
n-resistant mycobacteriosis or with rifampicin intolerance, Rifabutin
is the preferable drug in patients infected with mycobacteria who conc
omitantly receive immunosuppressive drugs, because interactions with t
hese are less prominent than with rifampicin.